MACROGENICS INC. - COMMON STOCK

MacroGenics Announces Appointment of William Heiden to Board of Directors

23 مايو 2022 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conference

17 مايو 2022 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress and First Quarter 2022 Financial Results

03 مايو 2022 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Date of First Quarter 2022 Financial Results Conference Call

25 أبريل 2022 15:11:56 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

03 مارس 2022 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress and 2021 Financial Results

24 فبراير 2022 15:01:01 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Date of Fourth Quarter 2021 Financial Results Conference Call

14 فبراير 2022 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

03 فبراير 2022 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

03 نوفمبر 2021 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results

02 نوفمبر 2021 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Date of Third Quarter 2021 Financial Results Conference Call

26 أكتوبر 2021 15:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Preliminary Clinical Results from Phase 1 Cohort Expansion of the Ongoing MGC018 Study Presented at ESMO 2021 Virtual Annual Congress

16 سبتمبر 2021 01:45:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuximab in Combination with Retifanlimab in Gastroesophageal Adenocarcinoma at ESMO 2021

16 سبتمبر 2021 01:45:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Presentations at ESMO 2021 Virtual Annual Congress

12 سبتمبر 2021 18:00:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Final Overall Survival Results from SOPHIA Study of MARGENZA™ in Patients with HER2-Positive Metastatic Breast Cancer

07 سبتمبر 2021 15:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

02 سبتمبر 2021 15:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

05 أغسطس 2021 15:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress and Second Quarter 2021 Financial Results

29 يوليو 2021 15:01:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Date of Second Quarter 2021 Financial Results Conference Call

22 يوليو 2021 15:05:01 بحسب Nasdaq GlobeNewswire

MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology

16 يونيو 2021 06:30:00 بحسب Nasdaq GlobeNewswire